ATXCo is Biotechnology in United States that focus on nonalcoholic steatohepatitis business. They cover business area such as developer, I, autotaxin inhibitor, idiopathic pulmonary fibrosis, NASH, (nonalcoholic steatohepatitis, PBC, primary biliary cholangitis, scleroderma, kidney disease.
-
Nonalcoholic Steatohepatitis
-
3030 Bunker Hill Street
Suite 325
San Diego, CA 92109
United States
Private
developerIautotaxin inhibitoridiopathic pulmonary fibrosisNASH(nonalcoholic steatohepatitisPBCprimary biliary cholangitissclerodermakidney disease
* We use standard office opening hours in near ATXCo's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
ATXCo is Biotechnology business from United States that founded in - ( years old in ), ATXCo business is focusing on Nonalcoholic Steatohepatitis.
ATXCo headquarter office and corporate office address is located in 3030 Bunker Hill Street Suite 325 San Diego, CA 92109 United States.
ATXCo was founded in United States.
In , ATXCo is currently focus on nonalcoholic steatohepatitis sector.
Above is snippet of Google Trends for "nonalcoholic steatohepatitis" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with ATXCo, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
